TheraCare Medicated Pain Relief Patches CAMPHOR, MENTHOL, METHYL SALICYLATE 3.1 g/100g; 6 g/100g; 10 g/100g Patch — NDC 71101-909-06 (Billing 71101-0909-06)
This is a package of TheraCare Medicated Pain Relief Patches CAMPHOR, MENTHOL, METHYL SALICYLATE 3.1 g/100g; 6 g/100g; 10 g/100g Patch from Veridian Healthcare, marketed since Mar 2023 and currently FDA-listed. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1793147
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
TheraCare Medicated Pain Relief Patches is a topical patch product sold as an over-the-counter monograph drug. It contains camphor, menthol, and methyl salicylate, which are commonly used as topical pain-relief and counterirritant ingredients. When applied to the skin, these substances are typically used to create a warming or cooling sensation and to help reduce minor muscle and joint discomfort. The patch format allows the active ingredients to be delivered directly to the affected area.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 71101-0909-06 You're viewing this Main listing | 6 PATCH in 1 BOX / 9 g in 1 PATCH | 2023-03-01 | — | Active |
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII U333RI6EB7
Hydrogenated polydecene type I is a synthetic oil derived from plant-based polymers. It acts as a lubricant and glidant to help powder ingredients flow smoothly during tablet or capsule manufacturing.
-
UNII 6ZAE7X688J
A refined mineral oil derived from crude petroleum. It serves as a lubricant and binder in tablet and capsule formulations, helping medicines slide smoothly through manufacturing equipment and improving how ingredients stick together.
-
UNII 255PIF62MS
A synthetic antioxidant compound used to prevent oils and fats in medications from breaking down or becoming rancid during storage. It helps maintain the medicine's stability and shelf life.
-
UNII 5Z4DPO246A
A synthetic plastic polymer made from styrene and acrylamide monomers. It acts as a film-former and binder in tablets and capsules, helping hold ingredients together and control how quickly the medicine dissolves and releases in your body.
4 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Indication and Usage For temporary relief of minor aches and pains.
⏱️ Dosage and Administration ▾
Directions Adults and children 12 years of age and over: Clean and dry affected area. Remove patch from film, apply to affected area not more than 3 to 4 times daily. Remove patch from the skin after at most, 8-hour application.
Children under 12 years of age: consult physician. Inactive Ingredients Hydrogenated Poly, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Petroleum, Styrene / Isoprene Copolymer Indication and Usage For temporary relief of minor aches and pains.
⚠️ Warnings ▾
For External Use Only Allergy alert: If prone to allergic reaction from asprin or salicylates, consult a doctor before use
🧪 Active Ingredient ▾
Active Ingredients Active Ingredients Purpose Camphor 3.1% ......................Topical Analgesic Menthol 6.0% .......................Topical Analgesic Methyl Salicylate 10.0% .......Topical Analgesic
🧪 Inactive Ingredients ▾
Inactive Ingredients Hydrogenated Poly, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Petroleum, Styrene / Isoprene Copolymer
🎯 Purpose ▾
Uses For temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, and bruises.
📄 Do Not Use ▾
Do not use: On wounds or damaged skin With a heating pad If you are allergic to any ingredients of this product
📄 When Using This Product ▾
When using this product Use only as directed Avoid contact with eyes, mucous membranes or rashes Do not bandage tighly Do not use at the same time as other topical analgesics Dispose of used patch in manner that keeps product away from childrens and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.
📄 Stop Use and Ask a Doctor If ▾
Stop use and consult a doctor If rash, itching or excessive skin irritation develops If condition worsens if symptoms last more than 7 days or clear up and occur again with a few days
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (800-222-1222) right away
📄 Other Information ▾
Other information Store in a clean, dry place outside of direct sunlight. Protect from excessive moisture.
📄 Package Label / Principal Display Panel ▾
Pain Relief Patch Label label
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |